The expression of insulin-like growth factor-1 in senior patients with diabetes and dementia

Zhou,Yan‑Ling; Liu,Shu‑Qing; Yuan,Bin; Lu,Ning

doi:10.3892/etm.2016.3961

The expression of insulin-like growth factor-1 in senior patients with diabetes and dementia

Authors:
- Yan‑Ling Zhou
- Shu‑Qing Liu
- Bin Yuan
- Ning Lu
View Affiliations

Affiliations: Department of Neurology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264003, P.R. China, Department of Neurology, Linglong Yingcheng Hospital, Zhaoyuan, Shandong 265400, P.R. China, Department of Neurology, Affiliated Hospital of Heze Medical College, Heze, Shandong 274000, P.R. China, Department of Geriatric Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264003, P.R. China
Published online on: December 6, 2016 https://doi.org/10.3892/etm.2016.3961
Pages: 103-106
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study was conducted to investigate the expression of insulin-like growth factor-1 (IGF-1) in elderly patients with diabetes and dementia and to analyze the expression mechanism. A total of 30 senior patients with diabetes and dementia (group A), 30 senior patients with dementia but no diabetes (group B), 30 senior patients with diabetes but no dementia (group C), and 30 healthy seniors (group D) were continuously selected. The ELISA method was used to test the level of serum IGF‑1, β‑amyloid peptide (Aβ) and the phosphorylation of immunohistochemical staining of microtubule associated protein (tau protein). Western blot analysis was utilized to test the level of prion protein (PrP), forkhead transcription factor O (FOXO) subfamily protein, p-PI3K and p-Akt. The levels of IGF‑1, Aβ, tau protein positive rate, PrP, FOXO protein, p‑PI3K, and p‑Akt in group A were significantly higher than that in group B, which was higher than in groups C and D. The results between groups A and B, but not groups C and D, were statistically significant (P<0.05). IGF‑1 was highly expressed in senior patients with diabetes and dementia. Thus, IGF‑1 can adjust the expression of PrP and FOXO through p-PI3K/Akt pathway and further impact the formation of Aβ and tau protein, leading to dementia.

View Figures

View References

1	Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, et al: LADIS study: White matter changes and diabetes predict cognitive decline in the elderly: The LADIS study. Neurology. 75:160–167. 2010. View Article : Google Scholar : PubMed/NCBI
2	Rasgon N and Jarvik L: Insulin resistance, affective disorders, and Alzheimer's disease: Review and hypothesis. J Gerontol A Biol Sci Med Sci. 59:178–183; discussion 184–192. 2004. View Article : Google Scholar : PubMed/NCBI
3	Freude S, Schilbach K and Schubert M: The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: From model organisms to human disease. Curr Alzheimer Res. 6:213–223. 2009. View Article : Google Scholar : PubMed/NCBI
4	White MF: Regulating insulin signaling and beta-cell function through IRS proteins. Can J Physiol Pharmacol. 84:725–737. 2006. View Article : Google Scholar : PubMed/NCBI
5	Jeong HJ, Jeong HW, Song SS, Kang JW, Seo JH, Lee YH, Lee KS and Kim DW: Upregulation of peroxiredeoxin III in the hippocampus of acute immobilization stress model rats and the Foxo3a-dependent expression in PC12 cells. Cell Mol Neurobiol. 31:1041–1046. 2011. View Article : Google Scholar : PubMed/NCBI
6	Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA and Klein WL: Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J. 22:246–260. 2008. View Article : Google Scholar : PubMed/NCBI
7	Roychaudhuri R, Yang M, Hoshi MM and Teplow DB: Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem. 284:4749–4753. 2009. View Article : Google Scholar : PubMed/NCBI
8	Haass C and Selkoe DJ: Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 8:101–112. 2007. View Article : Google Scholar : PubMed/NCBI
9	Bate C and Williams A: Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins. J Biol Chem. 286:37955–37963. 2011. View Article : Google Scholar : PubMed/NCBI
10	Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, et al: ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science. 335:1503–1506. 2012. View Article : Google Scholar : PubMed/NCBI
11	Deochand C, Tong M, Agarwal AR, Cadenas E and de la Monte SM: Tobacco smoke exposure impairs brain insulin/IGF signaling: Potential co-factor role in neurodegeneration. J Alzheimers Dis. 50:373–386. 2015. View Article : Google Scholar
12	Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R and O'Neill C: Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 31:224–243. 2010. View Article : Google Scholar : PubMed/NCBI
13	Adlerz L, Holback S, Multhaup G and Iverfeldt K: IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J Biol Chem. 282:10203–10209. 2007. View Article : Google Scholar : PubMed/NCBI
14	Zhang H, Gao Y, Dai Z, Meng T, Tu S and Yan Y: IGF-1 reduces BACE-1 expression in PC12 cells via activation of PI3-K/Akt and MAPK/ERK1/2 signaling pathways. Neurochem Res. 36:49–57. 2011. View Article : Google Scholar : PubMed/NCBI
15	Wang PJ, Zhang Y, Song RR and Shen DF: Study of the protection and mechanism of IGF-1 on tau protein hyperphosphorylation in PC12 cells induced by Abeta(1–40). Sichuan Da Xue Xue Bao Yi Xue Ban. 41:960–964. 2010.(In Chinese). PubMed/NCBI
16	Puig O, Marr MT, Ruhf ML and Tjian R: Control of cell number by Drosophila FOXO: Downstream and feedback regulation of the insulin receptor pathway. Genes Dev. 17:2006–2020. 2003. View Article : Google Scholar : PubMed/NCBI
17	Kim SJ, Winter K, Nian C, Tsuneoka M, Koda Y and McIntosh CH: Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem. 280:22297–22307. 2005. View Article : Google Scholar : PubMed/NCBI
18	Accili D and Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 117:421–426. 2004. View Article : Google Scholar : PubMed/NCBI
19	Zhao X, Gan L, Pan H, Kan D, Majeski M, Adam SA and Unterman TG: Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: Characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J. 378:839–849. 2004. View Article : Google Scholar : PubMed/NCBI
20	Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2011–2015. 2004. View Article : Google Scholar : PubMed/NCBI
21	Dick O and Bading H: Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors. J Biol Chem. 285:19354–19361. 2010. View Article : Google Scholar : PubMed/NCBI